What is Zacks Research’s Estimate for CLB FY2026 Earnings?

Core Laboratories Inc. (NYSE:CLB) – Zacks Research lowered their FY2026 earnings estimates for Core Laboratories in a research note issued on Monday, September 14th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of $0.61 for the year, down from their prior forecast of $0.62. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2027 earnings at $0.18 EPS, Q4 2027 earnings at $0.22 EPS, FY2027 earnings at $0.78 EPS, Q1 2028 earnings at $0.12 EPS and Q2 2028 earnings at $0.39 EPS.

Several other equities research analysts have also commented on CLB. Weiss Ratings raised Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, August 3rd. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Johnson Rice raised Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $21.00.

Core Laboratories Price Performance

Shares of NYSE CLB opened at $12.25 on Wednesday. The firm has a market capitalization of $562.09 million, a P/E ratio of 21.87, a PEG ratio of 2.42 and a beta of 1.08. Core Laboratories has a one year low of $9.79 and a one year high of $20.36. The company’s fifty day moving average is $11.83 and its two-hundred day moving average is $13.68. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.55 and a current ratio of 2.12.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The company had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. During the same quarter in the previous year, the company earned $0.19 EPS. The firm’s revenue for the quarter was down 4.3% compared to the same quarter last year. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS.

Institutional Investors Weigh In On Core Laboratories

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of Core Laboratories during the second quarter worth about $86,910,000. Dimensional Fund Advisors LP raised its position in shares of Core Laboratories by 10.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,352,329 shares of the oil and gas company’s stock valued at $22,705,000 after acquiring an additional 122,718 shares in the last quarter. Heartland Advisors Inc. bought a new position in shares of Core Laboratories in the 2nd quarter worth about $12,329,000. UBS Group AG lifted its holdings in Core Laboratories by 32.9% in the fourth quarter. UBS Group AG now owns 412,515 shares of the oil and gas company’s stock worth $6,613,000 after acquiring an additional 102,151 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in shares of Core Laboratories in the 2nd quarter worth approximately $4,675,000. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Insider Activity at Core Laboratories

In related news, CEO Lawrence Bruno bought 5,000 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The shares were acquired at an average cost of $10.78 per share, for a total transaction of $53,900.00. Following the acquisition, the chief executive officer owned 262,438 shares in the company, valued at $2,829,081.64. This represents a 1.94% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.26% of the company’s stock.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Monday, August 10th were issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.3%. The ex-dividend date was Monday, August 10th. Core Laboratories’s dividend payout ratio is currently 7.14%.

Core Laboratories News Roundup

Here are the key news stories impacting Core Laboratories this week:

• Positive Sentiment: Zacks raised its FY2027 EPS forecast to $0.78 from $0.77, lifted Q3 2027 EPS to $0.18 from $0.16, and increased Q1 2028 EPS to $0.12 from $0.11. The firm also raised Q2 2028 EPS to $0.39 from $0.31 and FY2028 EPS to $1.11 from $1.10, providing a favorable longer-term earnings outlook. Core Laboratories analyst estimate revisions
• Neutral Sentiment: The revisions leave Zacks’ current full-year consensus estimate at $0.56 EPS, while the company’s latest quarter showed EPS of $0.11, above expectations, but revenue declined 4.3% year over year to $124.61 million. Core Laboratories has guided to Q3 2026 EPS of $0.12-$0.20.
• Negative Sentiment: Zacks lowered its FY2026 EPS forecast to $0.61 from $0.62, reduced Q3 2026 EPS to $0.17 from $0.18, and cut Q4 2027 EPS to $0.22 from $0.24. These reductions point to some near-term earnings pressure and temper the impact of the longer-term upgrades. Core Laboratories earnings estimates

Core Laboratories Company Profile

Core Laboratories N.V. (NYSE: CLB) is a global provider of reservoir description and production enhancement services for the oil and natural gas industry. The company helps exploration and production companies evaluate subsurface formations, characterize reservoirs and improve the recovery of hydrocarbons from existing fields.

Core Laboratories’ reservoir description activities include laboratory analysis of rock and fluid samples, core analysis, special core analysis, fluid and pressure-volume-temperature studies, geochemical services and related geological and petrophysical evaluations.